| Primary |
| Computerised Tomogram Abdomen |
32.1% |
| Computerised Tomogram |
19.4% |
| Computerised Tomogram Thorax |
9.1% |
| Angiogram |
8.1% |
| Arteriogram Coronary |
8.1% |
| Drug Use For Unknown Indication |
7.6% |
| Product Used For Unknown Indication |
2.5% |
| Premedication |
2.1% |
| Hypertension |
1.3% |
| Myocardial Ischaemia |
1.3% |
| Computerised Tomogram Head |
1.2% |
| Percutaneous Coronary Intervention |
1.2% |
| Venous Pressure Abnormal |
1.0% |
| Angiogram Cerebral |
0.8% |
| Urogram |
0.8% |
| Abdominal Pain |
0.7% |
| Arteriogram |
0.7% |
| Aortic Dissection |
0.6% |
| Catheterisation Cardiac |
0.6% |
| Cerebral Infarction |
0.6% |
|
| Urticaria |
47.1% |
| Pruritus |
7.4% |
| Vomiting |
6.4% |
| Blood Pressure Decreased |
4.6% |
| Sneezing |
4.0% |
| Contrast Media Reaction |
3.8% |
| Rash |
3.2% |
| Throat Irritation |
3.2% |
| Respiratory Arrest |
2.3% |
| Shock |
2.1% |
| Adverse Event |
2.0% |
| Dyspnoea |
2.0% |
| Throat Tightness |
2.0% |
| Loss Of Consciousness |
1.5% |
| Ocular Hyperaemia |
1.5% |
| Tremor |
1.5% |
| Nausea |
1.4% |
| Wheezing |
1.4% |
| Adverse Drug Reaction |
1.2% |
| Procedural Complication |
1.2% |
|
| Secondary |
| Computerised Tomogram Abdomen |
30.6% |
| Angiogram |
10.6% |
| Angina Pectoris |
10.0% |
| Computerised Tomogram |
6.9% |
| Percutaneous Coronary Intervention |
6.3% |
| Venous Pressure Abnormal |
5.6% |
| Coronary Artery Occlusion |
4.4% |
| Drug Use For Unknown Indication |
3.8% |
| Chest Pain |
3.1% |
| Acute Myocardial Infarction |
2.5% |
| Dyspnoea Exertional |
2.5% |
| Procedural Hypotension |
2.5% |
| Abdominal Pain |
1.9% |
| Arteriogram Coronary |
1.9% |
| Coronary Artery Disease |
1.9% |
| Angina Unstable |
1.3% |
| Angioplasty |
1.3% |
| Diabetes Mellitus |
1.3% |
| Nasal Cavity Mass |
1.3% |
| Abdominal Pain Lower |
0.6% |
|
| Urticaria |
42.0% |
| Pruritus |
9.9% |
| Anaphylactoid Shock |
4.9% |
| Contrast Encephalopathy |
4.9% |
| Extravasation |
4.9% |
| Aneurysm Ruptured |
3.7% |
| Rash |
3.7% |
| Throat Irritation |
3.7% |
| Tremor |
3.7% |
| Adverse Event |
2.5% |
| Oedema |
2.5% |
| Scratch |
2.5% |
| Vomiting |
2.5% |
| Abdominal Discomfort |
1.2% |
| Erythema |
1.2% |
| Haemoptysis |
1.2% |
| Lip Swelling |
1.2% |
| Neurological Decompensation |
1.2% |
| Pruritus Generalised |
1.2% |
| Rash Maculo-papular |
1.2% |
|
| Concomitant |
| Hypoparathyroidism |
16.5% |
| Thyroid Cancer |
16.5% |
| Weight Decreased |
16.5% |
| Hypertension |
9.1% |
| Arrhythmia Prophylaxis |
8.2% |
| Hypothyroidism |
8.2% |
| Product Used For Unknown Indication |
4.0% |
| Scan With Contrast |
2.7% |
| Hepatic Neoplasm Malignant |
2.4% |
| Diabetes Mellitus |
1.8% |
| Diagnostic Procedure |
1.8% |
| Dyspepsia |
1.8% |
| Computerised Tomogram |
1.5% |
| Computerised Tomogram Abdomen |
1.5% |
| Abdominal Pain |
1.2% |
| Breast Cancer Metastatic |
1.2% |
| Depression |
1.2% |
| Insomnia |
1.2% |
| Percutaneous Coronary Intervention |
1.2% |
| Rash |
1.2% |
|
| Cardiac Arrest |
47.6% |
| Hypertension |
21.4% |
| Urticaria |
7.1% |
| Headache |
4.8% |
| Syncope |
4.8% |
| Acute Coronary Syndrome |
2.4% |
| Amnesia |
2.4% |
| Nephrogenic Fibrosing Dermopathy |
2.4% |
| Nephrogenic Systemic Fibrosis |
2.4% |
| Pruritus |
2.4% |
| Swelling |
2.4% |
|
